Showing results (71-80 of 347) with videos related to
Sort By:
Pageof 35
Journal of Drugs in Dermatology : JDD|July 8, 2025
Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported OutcomesCharlotte Jeong, Leon Kircik, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|June 4, 2011
Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitisAmylynne Frankel, Andrew Sohn, Rita V Patel, et al.Journal of the American Academy of Dermatology|April 25, 2009
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus ConferenceRobert E Kalb, Bruce Strober, Gerald Weinstein, et al.Cutis|May 19, 2009
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasisMark Lebwohl, Jean-Paul Ortonne, Philippe Andres, et al.Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.The Journal of Clinical and Aesthetic Dermatology|December 6, 2013
Infrared camera evaluation of the cooling effect of triamcinolone acetonide aerosolRita V Linkner, Andrew Sohn, Kristin A Goldenberg, et al.Journal of Drugs in Dermatology : JDD|August 10, 2022
Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic TherapiesRichard Fried, Mark Lebwohl, Miriam Bettencourt, et al.Journal of Drugs in Dermatology : JDD|July 8, 2025
Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic KeratosisAlyssa M Roberts, Leon Kircik, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|August 9, 2023
Talquetamab-Induced Grover's DiseaseMindy Kresch, Sophie Guenin, Adnan Mubasher, et al.Journal of Drugs in Dermatology : JDD|March 17, 2017
Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled TrialsShelbi Jim On, Kim Mark Knudsen, Torsten Skov, et al.Pageof 35